AsiaTIDES: Oligonucleotide & Peptide Therapeutics is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
The PolyPeptide Group is a privately-held group of manufacturing companies who focuses on proprietary and generic GMP-grade peptides for the pharmaceutical and biotechnological market. With more than 60 years of experience, the Group is committed to the highest quality of peptide manufacturing, irrespective of whether this is for approved drug substances, GMP peptides in clinical trials, or small-scale non-GMP custom syntheses.
Since its inception the PolyPeptide Group has grown by selective acquisition of existing expertise, culminating in its position today as the undisputed number two peptide manufacturing organization in the world. The Group has manufacturing facilities in Belgium (Braine L’Alleu), Sweden (Malmo) France (Strasbourg), India (Ambernath) and two sites in the USA (San Diego CA & Torrance CA). As a multinational company with about 800 employees worldwide, its diversity brings breadth and depth of knowledge and experience to the Group.
The Group's long-established core strength in GMP manufacturing and broad range of services supports peptide & peptide-like projects from their conception through to commercialization. With its increased capacity for GMP manufacturing and expanded capabilities for small-scale non GMP-custom peptides, the PolyPeptide Group is stronger and better equipped to serve the needs of its customers at all stages of pharmaceutical peptide development. With its multinational organization, strict focus on peptides and solid financial base, the Group offers an almost unique security of supply to its customers.